Low-dose naltrexone for treatment of multiple sclerosis: clinical trials are needed.
Patel
Priti N
PN
D002986:Clinical Trials as Topic; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use
D009292:Narcotic Antagonists; D009271:Naltrexone